CDKN2A and mantle cell lymphoma: RNA-seq analysis of specimens from MCL patients also revealed that CDK4 mRNA was significantly upregulated in ibrutinib-resistant MCL cells (Fig. 7a), in line with the observation of frequent deletion of CDKN2A in MCL (Fig. 1a).